<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0001907'>Thromboembolic disease</z:hpo> is a well-recognized but very uncommon complication of <z:e sem="disease" ids="C0021390" disease_type="Disease or Syndrome" abbrv="">inflammatory bowel disease</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>The mechanisms of the increased risk of <z:mp ids='MP_0005048'>thrombosis</z:mp> are not well understood: although several <z:hpo ids='HP_0001928'>coagulation abnormalities</z:hpo> have been described in <z:e sem="disease" ids="C0021390" disease_type="Disease or Syndrome" abbrv="">inflammatory bowel disease</z:e> patients, it is not clear whether they actually contribute to hypercoagulation or whether they are nonspecific markers of <z:mp ids='MP_0001845'>inflammation</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0003613'>Antiphospholipid antibodies</z:hpo> (anticardiolipin antibodies and/or <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi>) have recently been associated with an increased risk of <z:mp ids='MP_0005048'>thrombosis</z:mp>, particularly cerebrovascular disease in young patients </plain></SENT>
<SENT sid="3" pm="."><plain>We report the case of a 33-yr-old female with severe <z:hpo ids='HP_0100279'>ulcerative colitis</z:hpo> at first attack who developed <z:mp ids='MP_0005048'>thrombosis</z:mp> of the superior and inferior longitudinal dural sinuses </plain></SENT>
<SENT sid="4" pm="."><plain>No risk factors for <z:mp ids='MP_0005048'>thrombosis</z:mp> or <z:hpo ids='HP_0001928'>coagulation abnormalities</z:hpo> were observed; however, <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> was detected in the serum </plain></SENT>
<SENT sid="5" pm="."><plain>The patient was successfully treated with osmotic agents, prophylactic <z:chebi fb="0" ids="35623">anticonvulsant</z:chebi>, and antiplatelet therapy, combined with i.v. steroids </plain></SENT>
<SENT sid="6" pm="."><plain>After 6 months, the <z:hpo ids='HP_0002583'>colitis</z:hpo> is in remission, and the neurological recovery is good even if not yet complete </plain></SENT>
</text></document>